Alternative Strategies to Reduce Maternal Mortality in India: A Cost-Effectiveness Analysis
Background:
Approximately one-quarter of all pregnancy- and delivery-related maternal deaths worldwide occur in India. Taking into account the costs, feasibility, and operational complexity of alternative interventions, we estimate the clinical and population-level benefits associated with strategies to improve the safety of pregnancy and childbirth in India.
Methods and Findings:
Country- and region-specific data were synthesized using a computer-based model that simulates the natural history of pregnancy (both planned and unintended) and pregnancy- and childbirth-associated complications in individual women; and considers delivery location, attendant, and facility level. Model outcomes included clinical events, population measures, costs, and cost-effectiveness ratios. Separate models were adapted to urban and rural India using survey-based data (e.g., unmet need for birth spacing/limiting, facility births, skilled birth attendants). Model validation compared projected maternal indicators with empiric data. Strategies consisted of improving coverage of effective interventions that could be provided individually or packaged as integrated services, could reduce the incidence of a complication or its case fatality rate, and could include improved logistics such as reliable transport to an appropriate referral facility as well as recognition of referral need and quality of care. Increasing family planning was the most effective individual intervention to reduce pregnancy-related mortality. If over the next 5 y the unmet need for spacing and limiting births was met, more than 150,000 maternal deaths would be prevented; more than US$1 billion saved; and at least one of every two abortion-related deaths averted. Still, reductions in maternal mortality reached a threshold (∼23%–35%) without including strategies that ensured reliable access to intrapartum and emergency obstetrical care (EmOC). An integrated and stepwise approach was identified that would ultimately prevent four of five maternal deaths; this approach coupled stepwise improvements in family planning and safe abortion with consecutively implemented strategies that incrementally increased skilled attendants, improved antenatal/postpartum care, shifted births away from home, and improved recognition of referral need, transport, and availability/quality of EmOC. The strategies in this approach ranged from being cost-saving to having incremental cost-effectiveness ratios less than US$500 per year of life saved (YLS), well below India's per capita gross domestic product (GDP), a common benchmark for cost-effectiveness.
Conclusions:
Early intensive efforts to improve family planning and control of fertility choices and to provide safe abortion, accompanied by a paced systematic and stepwise effort to scale up capacity for integrated maternal health services over several years, is as cost-effective as childhood immunization or treatment of malaria, tuberculosis, or HIV. In just 5 y, more than 150,000 maternal deaths would be averted through increasing contraception rates to meet women's needs for spacing and limiting births; nearly US$1.5 billion would be saved by coupling safe abortion to aggressive family planning efforts; and with stepwise investments to improve access to pregnancy-related health services and to high-quality facility-based intrapartum care, more than 75% of maternal deaths could be prevented. If accomplished over the next decade, the lives of more than one million women would be saved.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Alternative Strategies to Reduce Maternal Mortality in India: A Cost-Effectiveness Analysis. PLoS Med 7(4): e32767. doi:10.1371/journal.pmed.1000264
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000264
Souhrn
Background:
Approximately one-quarter of all pregnancy- and delivery-related maternal deaths worldwide occur in India. Taking into account the costs, feasibility, and operational complexity of alternative interventions, we estimate the clinical and population-level benefits associated with strategies to improve the safety of pregnancy and childbirth in India.
Methods and Findings:
Country- and region-specific data were synthesized using a computer-based model that simulates the natural history of pregnancy (both planned and unintended) and pregnancy- and childbirth-associated complications in individual women; and considers delivery location, attendant, and facility level. Model outcomes included clinical events, population measures, costs, and cost-effectiveness ratios. Separate models were adapted to urban and rural India using survey-based data (e.g., unmet need for birth spacing/limiting, facility births, skilled birth attendants). Model validation compared projected maternal indicators with empiric data. Strategies consisted of improving coverage of effective interventions that could be provided individually or packaged as integrated services, could reduce the incidence of a complication or its case fatality rate, and could include improved logistics such as reliable transport to an appropriate referral facility as well as recognition of referral need and quality of care. Increasing family planning was the most effective individual intervention to reduce pregnancy-related mortality. If over the next 5 y the unmet need for spacing and limiting births was met, more than 150,000 maternal deaths would be prevented; more than US$1 billion saved; and at least one of every two abortion-related deaths averted. Still, reductions in maternal mortality reached a threshold (∼23%–35%) without including strategies that ensured reliable access to intrapartum and emergency obstetrical care (EmOC). An integrated and stepwise approach was identified that would ultimately prevent four of five maternal deaths; this approach coupled stepwise improvements in family planning and safe abortion with consecutively implemented strategies that incrementally increased skilled attendants, improved antenatal/postpartum care, shifted births away from home, and improved recognition of referral need, transport, and availability/quality of EmOC. The strategies in this approach ranged from being cost-saving to having incremental cost-effectiveness ratios less than US$500 per year of life saved (YLS), well below India's per capita gross domestic product (GDP), a common benchmark for cost-effectiveness.
Conclusions:
Early intensive efforts to improve family planning and control of fertility choices and to provide safe abortion, accompanied by a paced systematic and stepwise effort to scale up capacity for integrated maternal health services over several years, is as cost-effective as childhood immunization or treatment of malaria, tuberculosis, or HIV. In just 5 y, more than 150,000 maternal deaths would be averted through increasing contraception rates to meet women's needs for spacing and limiting births; nearly US$1.5 billion would be saved by coupling safe abortion to aggressive family planning efforts; and with stepwise investments to improve access to pregnancy-related health services and to high-quality facility-based intrapartum care, more than 75% of maternal deaths could be prevented. If accomplished over the next decade, the lives of more than one million women would be saved.
: Please see later in the article for the Editors' Summary
Zdroje
1. World Health Organization (WHO) 2007 Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA, and The World Bank. Available: http://www.who.int/whosis/mme_2005.pdf. Accessed 19 August 2009
2. HillK
ThomasK
AbouZahrC
WalkerN
SayL
2007 Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data. Lancet 370 1311 1319
3. United Nations (UN) Millennium Development Goals: Goal 5 (MDG 5). Improve maternal health. Available: http://www.un.org/millenniumgoals/maternal.shtml. Accessed 31 July 2009
4. World Health Organization (WHO) 2005 Millennium Development Goals and Health–India. Chapter III: Goal 5: improve maternal health. Geneva: WHO. Available: http://www.whoindia.org/LinkFiles/MDG_Chapter-03.pdf. Accessed 31 July 2009
5. ShiffmanJ
VedR
2007 The state of political priority for safe motherhood in India. BJOG 114 785 90
6. RonsmansC
GrahamWJ
on behalf of The Lancet Maternal Survival Series steering group 2006 Maternal mortality: who, when, where and why. Lancet 368 1189 1200
7. GrahamWJ
CairnsJ
BhattacharyaS
BulloughCHW
QuayyumZ
2006 Chapter 26: Maternal and perinatal conditions.
JamisonDT
BremanJG
MeashamAR
AlleyneG
ClaesonM
Disease control priorities in developing countries. 2nd edition New York Oxford University Press 499 530 Available: http://www.dcp2.org/pubs/DCP/26/. Accessed 23 August 2009
8. CampbellOM
GrahamWJ
Lancet Maternal Survival Series steering group 2006 Strategies for reducing maternal mortality: getting on with what works. Lancet 368 1284 99
9. RosenfieldA
MaineD
FreedmanL
2006 Meeting MDG-5: an impossible dream? Lancet 368 1133 1135
10. Government of India 2005 Reproductive and Child Health Programme Document (RCH II–Document 2): the principles and evidence base for State RCH II Programme Implementation Plans (PIPs). New Delhi, India: Government of India. Available: http://www.whoindia.org/LinkFiles/Child_Health_in_India_PIP_Doc_Chapter01.pdf. Accessed 21 August 2009
11. Government of India, Ministry of Health and Family Welfare, Department of Family Welfare 2005 National rural healthcare mission. New Delhi, India: Government of India. Available: http://www.mohfw.nic.in/NRHM/Documents/NRHM%20Mission%20Document.pdf. Accessed 21 August 2009
12. ShiffmanJ
2007 Generating political priority for maternal mortality reduction in 5 developing countries. Am J Public Health 97 796 803
13. CostelloA
AzadK
BarnettS
2006 An alternative strategy to reduce maternal mortality. Lancet 368 1477 1479
14. MillsS
BosE
LuleE
RamanaGNV
BulataoR
2007 Obstetric care in poor settings in Ghana, India, and Kenya. Washington (D.C.): The World Bank. Available: http://www-wds.worldbank.org/servlet/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&entityID=000310607_20080123112201. Accessed 27 July 2009
15. Registrar General, India 2006 Maternal mortality in India: 1997–2003; trends, causes and risk factors. New Delhi, India. Available: http://www.mp.gov.in/health/Maternal_Mortality_in_India_1997-2003.pdf. Accessed 22 August 2009
16. GoldieSJ
Goldhaber-FiebertJD
GarnettGP
2006 Public health policy for cervical cancer prevention: role of decision science, economic evaluation, and mathematical modeling. Vaccine 24 S155 S163
17. AdamT
LimSS
MehtaS
BhuttaZA
FogstadH
2005 Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries. BMJ 331 1107
18. SutherlandT
BishaiD
2009 Cost-effectiveness of misoprostol and prenatal iron supplementation as maternal mortality interventions in home births in rural India. Int J Gynaecol Obstet 104 189 193
19. LevineR
LangerA
BirdsallN
MathenyG
WrightM
2006 Contraception. Disease control priorities in developing countries. 2nd edition New York Oxford University Press 1075 1090 Available at: http://www.dcp2.org/pubs/DCP
20. Terris-PrestholtF
Watson-JonesD
MugeyeK
KumaranayakeL
NdekiL
2003 Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect 79 375 381
21. NakhaeeN
MirahmadizadehAR
GorjiHA
MohammadiM
2002 Assessing the cost-effectiveness of contraceptive methods in Shiraz, Islamic Republic of Iran. East Mediterr Health J 8 55 63
22. PagelC
LewyckaS
ColbournT
MwansamboC
MequidT
2009 Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model. Lancet 374 1441 1448
23. HuD
BertozziSM
GakidouE
SweetS
GoldieSJ
2007 The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in Mexico. PLoS ONE 2 e750 doi:10.1371/journal.pone.0000750
24. PrataN
SreenivasA
GreigF
WalshJ
PottsM
2010 Setting priorities for safe motherhood interventions in resource-scarce settings. Health Policy 94 1 13
25. World Health Organization (WHO) CHOICE: choosing interventions that are cost-effective. Available: http://www.who.int/choice/en/. Accessed 12 July 2007
26. International Institute for Population Sciences (IIPS) 2005 Reproductive and child health project. Facility survey. DLHS-2, 2003. Available: http://www.rchiips.org/pdf/rch2/National_Facility_Report_RCH-II.pdf. Accessed 1 September 2009
27. Government of India 2008 Bulletin on rural health statistics in India. Rural health system in India. Available: http://www.mohfw.nic.in/Bulletin%20on%20RHS%20-%20March,%202008%20-%20PDF%20Version/Rural%20Health%20Care%20System%20in%20India.pdf. Accessed 1 September 2009
28. International Institute for Population Sciences (IIPS) and ORC Macro 2007 National Family Health Survey (NFHS-3), 2005–06: India. Mumbai: IIPS. Available: http://www.nfhsindia.org/nfhs3_national_report.html. Accessed 23 August 2009
29. KhanKS
WojdylaD
SayL
GulmezogluAM
Van LookPF
2006 WHO analysis of causes of maternal death: a systematic review. Lancet 367 1066 1074
30. JohnsB
SigurbjornsdottirK
FogstadH
ZupanJ
2007 Estimated global resources needed to attain universal coverage of maternal and newborn health services. Bull World Health Organ 85 256 263
31. World Health Organization (WHO) 2002 Estimates of DALYs by sex, cause and WHO mortality sub-region, estimates for 2001. Geneva: WHO. Available: http://www.who.int/healthinfo/global_burden_disease/estimates_regional_2001/en/index.html. Accessed 23 August 2009
32. World Health Organization (WHO) 2007 World Health Statistics. Available: http://www.who.int/healthinfo/statistics/gbdwhoregionincidence2002.xls. Accessed 7 May 2009
33. UNICEF 2004 State of the world's children. Available: http://www.unicef.org/sowc/archive/ENGLISH/The%20State%20of%20the%20World%27s%20Children%202004.pdf. Accessed 7 May 2009
34. DoleaC
AbouZahrC
SteinC
2003 Global burden of maternal hemorrhage in the year 2000. Geneva, Switzerland: World Health Organization. Available: http://www.who.int/healthinfo/statistics/bod_maternalhaemorrhage.pdf. Accessed 23 August 2009
35. DoleaC
AbouZahrC
2003 Global burden of obstructed labor in the year 2000. Geneva, Switzerland: World Health Organization. Available: http://www.who.int/healthinfo/statistics/bod_obstructedlabour.pdf. Accessed 23 August 2009
36. DoleaC
AbouZahrC
2003 Global burden of hypertensive disorders of pregnancy in the year 2000. Geneva, Switzerland: World Health Organization. Available: http://www.who.int/healthinfo/statistics/bod_hypertensivedisordersofpregnancy.pdf. Accessed 23 August 2009
37. DoleaC
SteinC
2003 Global burden of maternal sepsis in the year 2000. Geneva, Switzerland: World Health Organization. Available: http://www.who.int/healthinfo/statistics/bod_maternalsepsis.pdf. Accessed 23 August 2009
38. AbouZahrC
WardlawT
2004 Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. Geneva: World Health Organization. Available: http://www.who.int/reproductivehealth/publications/monitoring/9241562706/en/index.html. Accessed 23 August 2009
39. HenshawSK
SinghS
HaasT
1999 The incidence of abortion worldwide. Int Fam Plann Persp 25 S30 S38
40. ShahI
AhmanE
2004 Age patterns of unsafe abortion in developing country regions. Reprod Health Matters 12 S9 S17
41. BererM
2004 National laws and unsafe abortion: the parameters of change. Reprod Health Matters 12 1 8
42. The Alan Guttmacher Institute (AGI) 2006 Preventing unsafe abortion and its consequences: priorities for research and action. New York: Alan Guttmacher Institute. Available: http://www.guttmacher.org/pubs/2006/07/10/PreventingUnsafeAbortion.pdf. Accessed 24 August 2009
43. The Alan Guttmacher Institute (AGI) 2007 Facts on induced abortion worldwide: worldwide incidence and trends. Available: http://www.guttmacher.org/pubs/fb_IAW.html. Accessed 18 August 2009
44. LuleE
SinghS
ChowdurySA
2007 Fertility regulation behaviors and their costs: contraception and unintended pregnancies in Africa and Eastern Europe & Central Asia. Washington (D.C.): World Bank. Available: http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627-1095698140167/FertilityRegulationsFinal.pdf. Accessed 24 August 2009
45. MurrayCJL
LopezAD
1996 Estimating causes of death: new methods and global and regional applications for 1990.
MurrayCJL
LopezAD
The global burden of disease, vol. 1 of Global burden of disease and injury series Cambridge Harvard University Press 117 200
46. MurrayCJL
LopezAD
1998 Health dimensions of sex and reproduction. Cambridge Harvard School of Public Health
47. AhmanE
DoleaC
ShahI
2006 The global burden of unsafe abortion in the year 2000, Geneva: World Health Organization, Available: http://www.who.int/healthinfo/statistics/bod_abortions.pdf. Accessed 4 August 2008
48. SinghS
2006 Hospital admissions resulting from unsafe abortion: estimates from 13 developing countries. Lancet 368 1887 1892
49. BiswasAB
DasDK
MisraR
RoyRN
GhoshD
2005 Availability and use of emergency obstetric care services in four districts of West Bengal, India. J Health Popul Nutr 23 266 274
50. AhmanE
ShahI
2007 Unsafe abortion: global and regional estimates of unsafe abortion and associated mortality in 2003 (5th edn). Geneva: World Health Organization. Available: http://www.who.int/reproductivehealth/publications/unsafe_abortion/9789241596121/en/index.html. Accessed 24 August 2009
51. AhmanE
ShahI
2004 Unsafe abortion: global and regional estimates of unsafe abortion and associated mortality in 2000 (4th edn). Geneva: World Health Organization. Available: http://www.who.int/reproductivehealth/publications/unsafe_abortion/9241591803/en/index.html. Accessed 24 August 2009
52. GulmezogluAM
VillarJ
NgocNT
PiaggioG
CarroliG
2001 WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 358 689 695
53. JohansonRB
MenonBK
2000 Vacuum extraction versus forceps for assisted vaginal delivery. Cochrane Database Syst Rev 2 CD000224
54. HofmeyrGJ
KulierR
2000 External cephalic version for breech presentation at term. Cochrane Database Syst Rev 2 CD000083
55. HofmeyrGJ
HannahME
2003 Planned Caesarean section for term breech delivery. Cochrane Database Syst Rev 3 CD000166
56. SchuitemakerN
van RoosmalenJ
DekkerG
Van DongenP
van GeijnH
1997 Maternal mortality after cesarean section in The Netherlands. Acta Obstet Gynecol Scand 76 332 334
57. Magpie Trial Collaborative Group 2002 Do women with pre-eclampsia and their babies benefit from magnesium sulphate? The Magpie Trial: a randomised placebo controlled trial. Lancet 359 1877 1890
58. DuleyL
GülmezogluA
Henderson-SmartD
2003 Magnesium sulphate and other anticonvulsants for women with eclampsia. Cochrane Database Syst Rev 2 CD000025
59. CrowtherC
HillerJ
DoyleL
2002 Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 4 CD001060
60. FrenchLM
2003 Prevention and treatment of postpartum endometritis. Curr Womens Health Rep 4 274 279
61. FrenchLM
SmaillFM
2004 Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev 4 CD001067
62. KooninLM
SmithJC
RamickM
1993 Abortion surveillance–United States, 1990. MMWR CDC Surveill Summ 42 29 57
63. Institute of Medicine (IOM) 1975 Legalized abortion and the public health; report of a study by a committee of the Institute of Medicine. Washington (D.C.) National Academy of Sciences
64. GrimesDA
2005 Risks of mifepristone abortion in context. Contraception 71 161
65. World Bank 2002 India's transport sector: the challenges ahead. Vol 1. Washington (D.C.): World Bank Group. Available: http://www-wds.worldbank.org/external/default/main?pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&theSitePK=523679&entityID=000094946_02070604022321&searchMenuPK=64187283&theSitePK=523679. Accessed 23 August 2009
66. PMGSY (Pradhan Mantri Gram Sadak Yojana) 2006 Briefing book. Available: http://pmgsy.nic.in/. Accessed 27 July 27 2009
67. KatrakH
2008 Measuring the shortage of medical practitioners in rural and urban areas in developing countries: a simple framework and simulation exercise with data from India. Int J Health Plann Manage 23 93 105
68. MaS
SoodN
2008 A comparison of the health systems in China and India. Rand Corporation. Available: http://www.rand.org/pubs/occasional_papers/2008/RAND_OP212.pdf. Accessed 27 July 2009
69. HarlapS
ShionoPH
RamcharanS
1980 A life table of spontaneous abortions and the effects of age, parity and other variables.
PorterIH
HookEB
Human embryonic and fetal death New York Academic Press 145 158
70. MenkenJ
RahmanMO
2006 Chapter 3: Reproductive health.
MersonMH
BlackRE
MillsAJ
International public health: diseases, programs, systems, and policies, 2nd ed Sudsbury (Massachusetts) Jones and Bartlett Publishers 71 125
71. BrabinBJ
HakimiM
PelletierD
2001 An analysis of anemia and pregnancy-related maternal mortality. J Nutr 131 604S 614S
72. HofmeyrGJ
GulmezogluAM
2008 Misoprostol for the prevention and treatment of pospartum hemorrhage. Best Practice & Research Clinical Obstet and Gynaec 22 1025 1041
73. Cahuana-HurtadoL
Sosa-RubiS
BertozziS
2004 The application of the mother baby package reproductive health costing spreadsheet in Morelos: National Institute of Public Health, Division of Health Economics and Policy, Mexico
74. ThaddeusS
MaineD
1994 Too far to walk: maternal mortality in context. Soc Sci Med 38 1091 1110
75. International Institute for Population Sciences (IIPS) and ORC Macro 2007 National Family Health Survey (NFHS-3), 2005–06: India. Maternal health, Chapter 8. Mumbai: IIPS. 191–222 Available: http://www.nfhsindia.org/NFHS-3%20Data/VOL-1/india_volume_I_chapter_8_corrected_for_website_17oct08.pdf. Accessed 23 August 2009
76. International Institute for Population Sciences (IIPS) 2006 Reproductive and Child Health Project. District Level Household Survey. DLHS-2. 2002–2004. Available: http://www.rchiips.org/pdf/rch2/National_Report_RCH-II.pdf. Accessed 1 September 2009
77. International Institute for Population Sciences (IIPS) 2007 Fact sheet: Uttar Pradesh. Reproductive and Child Health Project. District Level Household and Facility Survey. DLHS-3. Available: http://www.rchiips.org/pdf/rch3/state/Uttar-Pradesh.pdf. Accessed 1 September 2009
78. International Institute for Population Sciences (IIPS) 2007 Fact sheet: Rajasthan. Reproductive and Child Health Project. District Level Household and Facility Survey. DLHS-3. Available: http://www.rchiips.org/pdf/rch3/state/Rajsthan.pdf. Accessed 1 September 2009
79. VoraKS
MavalankarDV
RamaniKV
UpadhyayaM
SharmaB
2009 Maternal health situation in India: a case study. J Health Popul Nutr 27 184 201
80. IyengarSD
IyengarK
GuptaV
2009 Maternal health: a case study of Rajasthan. J Health Popul Nutr 27 271 292
81. IyengarSD
IyengarK
SuhalkaV
AgarwalK
2009 Comparison of domiciliary and institutional delivery-care practices in Rural Rajasthan, India. J Health Popul Nutr 27 303 312
82. IyengarK
IyengarSD
SuhalkaV
DashoraK
2009 Pregnancy-related deaths in rural Rajasthan, India: exploring causes, context, and care-seeking through verbal autopsy. J Health Popul Nutr 27 293 302
83. MavalankarDV
VoraKS
RamaniKV
RamanP
SharmaB
2009 Maternal health in Gujarat, India: a case study. J Health Popul Nutr 27 235 248
84. AMDD Working Group on Indicators 2002 Program note: using UN process indicators to assess needs in emergency obstetric services: Bhutan, Cameroon and Rajasthan, India. Int J Gynaecol Obstet 77 277 284
85. World Health Organization (WHO) 2006 World Health Report: working together for health. Geneva: World Health Organization. Available: http://www.who.int/whr/2006/en/index.html. Accessed 23 August 2009
86. UNICEF, WHO, UNFPA 2007 Maternal mortality declining in middle-income countries; women still die in pregnancy and childbirth in low-income countries. UNICEF, WHO, UNFPA Joint Press Release. Available: http://www.unicef.org/media/media_41208.html. Accessed 27 July 2009
87. United Nations (UN), Department of Economic and Social Affairs, Population Division 2007 World Population Prospects: the 2006 revision. CD-ROM edition - extended dataset in Excel and ASCII formats. New York United Nations
88. UNFPA 2007 Reproductive Health Costing Tools Model. New York: UNFPA. Available: http://www.who.int/pmnch/topics/economics/costing_tools/en/index15.html. Accessed 27 July 2009
89. International Labour Organization (ILO) Laborsta database. Available: http://laborsta.ilo.org/. Accessed 27 July 2009
90. UNICEF Supply Division. Available: http://www.supply.unicef.dk/catalogue/. Accessed 27 July 2009
91. Management Sciences for Health (MSH). International Drug Price Indicator Guide (IDPIG). Available: http://erc.msh.org/mainpage.cfm?file=1.0.htm&id=1&temptitle=Introduction&module=DMP&language=English. Accessed 27 July 2009
92. DuggalR
2004 The political economy of abortion in India: cost and expenditure patterns. Reprod Health Matters 12 S130 S137
93. BorghiJ
EnsorT
SomanathanA
LissnerC
MillsA
on behalf of The Lancet Maternal Survival Series steering group 2006 Mobilising financial resources for maternal health. Lancet 368 1457 1465
94. BhatR
MavalankarDV
SinghPV
SinghN
2009 Maternal healthcare financing: Gujarat's Chiranjeevi Scheme and its beneficiaries. J Health Popul Nutr 27 249 258
95. JamisonDT
BremanJG
MeashamAR
AlleyneG
ClaesonM
2006 Disease control priorities in developing countries. 2nd edition. Washington (D.C.): The International Bank for Reconstruction and Development/The World Bank. Available: http://www.dcp2.org. Accessed 4 May 2009
96. LaxminarayanR
ChowJ
Shahid–SallesSA
2006 Intervention cost–effectiveness: overview of main messages. Disease control priorities in developing countries. 2nd edition. 35–86. New York: Oxford University Press. Available: http://www.dcp2.org/pubs/DCP/2/FullText. Accessed 4 May 2009
97. BrenzelL
WolfsonLJ
Fox-RushbyJ
MillerM
HalseyNA
2006 Vaccine–preventable diseases. Disease control priorities in developing countries. 2nd edition. 389-412. New York: Oxford University Press. Available: http://www.dcp2.org/pubs/DCP/20/FullText. Accessed 4 May 2009
98. World Health Organization (WHO) 2001 Macroeconomics and health: investing in health for economic development: report of the Commission on Macroeconomics and Health. Geneva World Health Organization
99. EkmanB
PathmanathanI
LiljestrandJ
2008 Integrating health interventions for women, newborn babies, and children: a framework for action. Lancet 372 990 1000
100. BangRA
BangAT
ReddyMH
DeshmukhMD
BaituleSB
2004 Maternal morbidity during labour and the puerperium in rural homes and the need for medical attention: A prospective observational study in Gadchiroli, India. BJOG 111 231 238
101. ShiffmanJ
SmithS
2007 Generation of political priority for global health initiatives: a framework and case study of maternal mortality. Lancet 370 1370 1379
102. FilippiV
RonsmansC
CampbellOM
GrahamWJ
MillsA
2006 Maternal health in poor countries: the broader context and a call for action. Lancet 368 1535 1541
103. National Rural Health Mission 2005–2012 Mission document. Available: http://india.gov.in/outerwin.php?id=http://mohfw.nic.in/NRHM/NRHM%28National%20Rural%20Health%20Mission%29.htm. Accessed 1 September 2009
104. PadmanabanP
RamanPS
MavalankarDV
2009 Innovations and challenges in reducing maternal mortality in Tamil Nadu, India. J Health Popul Nutr 27 202 219
105. PrakasammaM
2009 Maternal mortality-reduction programme in Andhra Pradesh. J Health Popul Nutr 27 220 234
106. McPakeB
KoblinskyM
2009 Improving maternal survival in South Asia-what can we learn from case studies? J Health Popul Nutr 27 93 107
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 4
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis
- China's Engagement with Global Health Diplomacy: Was SARS a Watershed?
- Laboratory Capacity Building in Asia for Infectious Disease Research: Experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN)